1. Stroke in Park's Text book of Preventive and Social Medicine.18th Edition. K Park(Ed) Jabalpur. India. Banarasidas Bhanot 2004.p 298-299. |
|
2. Wade S Smith, Johnston Sc, Donald Ej. Cerebrovascular diseases in Harrisons principles of Internal Medicine (vol 2) 15th ed, Braunwald Fauci, Kasper Hauser, Longo, Jameson(eds).North America. Mac Grawhill. 2004.p 2369-2391. |
|
3. Hatano S. Variability of diagnosis of stroke by clinical judgement and by a scoring method. Bull World Health Organ 1976; 54: 533-540. [Pubmed] [PMC Free Fulltext] |
|
4. Becker KJ. Inflammation and acute stroke. Current opinion in neurology.1998; 11:45-49. [DOI via Crossref] [Pubmed] |
|
5. Ross R. Atherosclerosis: an inflammatory disease. N Engl J of Med 1999; 340:115-126. [DOI via Crossref] [Pubmed] |
|
6. Ramadori G, Christ B.Cytokines and the hepatic acute phase. Semin Liver Dis 1999;19: 141-155. [DOI via Crossref] [Pubmed] |
|
7. Arvin B , Nivelle LF, Barone FC, Feurestein GZ. The role of inflammation and cytokines in brain injury.Neuro Sci BiobehavRev 1996;20: 445-452. [DOI via Crossref] |
|
8. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: New opportunities for novel therapies. J Cereb Blood flow Metab 1999; 19: 819-834. [DOI via Crossref] [Pubmed] |
|
9. Hallenback JM. The many faces of Tumor necrosis factor in Stroke. Nature Med 2002; 8: 1363-1368. [DOI via Crossref] [Pubmed] |
|
10. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system Expression and recognition. Trends Neuro ci 1995; 18: 130-136. |
|
11. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system II actions and mechanism of actions. Trends Neuro Sci 2000; 23: 618-625. |
|
12. Wilson JTL, Harendran A, Potter J, Bone I, Muir K W. Reliability of the modified Rankin Scale across Multiple Raters Benefits of a Structured Interview. Stroke 2005;36: 777-781. [DOI via Crossref] [Pubmed] |
|
13. Mahoney Florence I Barthel: Functional Evaluation: The Barthel Index. Maryland State Medical Journal 1965; Feb: 61-63. |
|
14. Hedayati M, Yazdanparast R, Azizi F.Determination of human tumor necrosis factor alpha by a highly sensitive enzyme immunoassay.Biochem Biophys Res Commun 2001; Nov: 23:289(1):295-298. |
|
15. Yuan CS. Methods and composition of assaying analytes. U.S Patent No. US 6,376, 210B1 (202). |
|
16. Bisdas S, Donnerstag F, Ahl B, Bohrer I, Weinssenborn K, Becker H. Comparison of perfusion computed tomography with diffusion weighted magnetic resonance imaging in hyperacute ischemic stroke. J. Comput. Assist. Tomogr 2004; 28(6): 747-755. [DOI via Crossref] [Pubmed] |
|
17. Siren AL, Eliahu H, David D, et al. Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive wistar Kyoto rats. Stroke 1992; 23: 1643-1651. [DOI via Crossref] [Pubmed] |
|
18. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor ñ, a mediator of focal ischemic brain injury. Stroke 1997; 28: 1233-1244. [DOI via Crossref] [Pubmed] |
|
19. Kochanek PM, Hallenbeck JM. Polymorphonuclear leucocytes and monocyte/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367-1379. [DOI via Crossref] |
|
20. Intiso D, Zarelli MM, Lagioia G, et al. Tumor Necrosis Factor Alpha Serum levels and inflammatory response in acute ischemic stroke patients. Neurosciences 2000; 24: 390-396. |
|
21. Ferrarese C, Masarucci P, Zoia C, et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood flow Metab 1999; 19: 1004-1009. [DOI via Crossref] [Pubmed] |
|
22. Zaremba J, Losy J. Early TNF âñ levels correlate with ischemic stroke severity. Acta Neurol Scan 2001;104: 288-295. [DOI via Crossref] |
|
23. Castillo J, Ira R. Biochemical changes and inflammatory response as markers for brain ischemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovas dis 204; 17(suppl 1):7-18. |
|
24. Bruce A J, Boling W, Kindy M S, et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med 1996; 2: 788-794. [DOI via Crossref] [Pubmed] |
|
25. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke 1999; 30:981-985. [DOI via Crossref] [Pubmed] |
|
26. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001; 32: 133-138. [DOI via Crossref] [Pubmed] |
|
27. Christensen H, Boysen G. C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke. Cerebrovascular diseases 2004; 18:214-219. [DOI via Crossref] [Pubmed] |
|
28. Di Napoli M. C-reactive protein and acute phase of ischemic stroke. BMJ 2001;322: 1605-1606. [Pubmed] [PMC Free Fulltext] |
|
29. Di Napoli M, Farncesca P, Bocola V. C-reactive protein in ischemic stroke. An independent prognostic factor. Stroke 2001; 32: 917-924 [DOI via Crossref] [Pubmed] |
|
30. Masotti L, Cecearelli E, Forconi S, Capelli R. Prognostic role of C-reactive protein in very old patients with acute ischemic stroke. Journal of Internal Medicine 2005; 258: 145-152. [DOI via Crossref] [Pubmed] |
|
31. Di Napoli M, Markus S, Roberto C, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke. A statement for Health care professionals from the CRP pooling project members. Stroke 2005; 36: 1316-1329. [DOI via Crossref] [Pubmed] |
|
32. Di Napoli M. Early inflammatory response in ischemic stroke. Thromb Res 2001; 103:261-264. [DOI via Crossref] |
|
33. Smith CJ. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischemic stroke correlate with brain infarct volume, stroke severity and long term outcome. BMC Neurology 2004; 4:2. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
34. Iyigun I, Bakirei Y. Plasma Concentrations of C-reactive protein and Fibrinogen in Ischemic Stroke. J Int Med Res. 2002;30: 591-596. [DOI via Crossref] [Pubmed] |
|
35. Silvestri A, Vitale C, Ferretti F, Onorati D, Fini M, Rosano GM. Plasma levels of C- reactive protein and interleukin -6 predict outcome in elderly patients with stroke. J Am Geriatric Soc 2004; 52: 1586-1587 [DOI via Crossref] [Pubmed] |
|